These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17727682)

  • 1. Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo.
    Yamasaki M; Fujita S; Ishiyama E; Mukai A; Madhyastha H; Sakakibara Y; Suiko M; Hatakeyama K; Nemoto T; Morishita K; Kataoka H; Tsubouchi H; Nishiyama K
    Cancer Sci; 2007 Nov; 98(11):1740-6. PubMed ID: 17727682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion.
    Kim MH; Gutierrez AM; Goldfarb RH
    Anticancer Res; 2002; 22(6C):3811-7. PubMed ID: 12552999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of soy phytoestrogens on rat L6 skeletal muscle cells.
    Jones KL; Harty J; Roeder MJ; Winters TA; Banz WJ
    J Med Food; 2005; 8(3):327-31. PubMed ID: 16176142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
    Martínez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
    Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
    Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
    Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
    Su SJ; Yeh TM; Lei HY; Chow NH
    Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model.
    Hewitt AL; Singletary KW
    Cancer Lett; 2003 Mar; 192(2):133-43. PubMed ID: 12668277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoflavones and gamma irradiation inhibit cell growth in human salivary gland cells.
    Katz J; Blake E; Medrano TA; Sun Y; Shiverick KT
    Cancer Lett; 2008 Oct; 270(1):87-94. PubMed ID: 18585854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
    Su SJ; Chow NH; Kung ML; Hung TC; Chang KL
    Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.
    Eskra JN; Schlicht MJ; Bosland MC
    Prostate; 2019 Feb; 79(2):223-233. PubMed ID: 30345530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lymphocyte activation.
    Wang W; Higuchi CM; Zhang R
    Nutr Cancer; 1997; 29(1):29-34. PubMed ID: 9383781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of α
    Huang R; Liu Y; Hu S; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones and cancer prevention.
    Sarkar FH; Li Y
    Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.
    Van der Eecken H; Joniau S; Berghen C; Rans K; De Meerleer G
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary isoflavones on proliferation and DNA integrity of myoblasts derived from newborn piglets.
    Mau M; Kalbe C; Viergutz T; Nürnberg G; Rehfeldt C
    Pediatr Res; 2008 Jan; 63(1):39-45. PubMed ID: 18043503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy for breast cancer survivors: a critical review of the literature.
    Messina MJ; Loprinzi CL
    J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
    Mahmoud AM; Yang W; Bosland MC
    J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.